|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
532190548 |
| 003 |
DE-627 |
| 005 |
20230905073055.0 |
| 007 |
tu |
| 008 |
070615s2007 sz ||||| 00| ||eng c |
| 020 |
|
|
|a 9789241209434
|9 978-92-4-120943-4
|
| 035 |
|
|
|a (DE-627)532190548
|
| 035 |
|
|
|a (DE-599)GBV532190548
|
| 035 |
|
|
|a (OCoLC)255547233
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-CH
|c XP
|
| 084 |
|
|
|a 58.28
|2 bkl
|
| 084 |
|
|
|a 44.40
|2 bkl
|
| 110 |
2 |
|
|a Weltgesundheitsorganisation
|b Expert Committee on Specifications for Pharmaceutical Preparations
|0 (DE-588)260051-1
|0 (DE-627)100116027
|0 (DE-576)190924039
|4 aut
|
| 245 |
1 |
0 |
|a Forty-first report / WHO Expert Committee on Specifications for Pharmaceutical Preparations
|b [the WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 16 to 20 October 2006]
|
| 264 |
|
1 |
|a Geneva
|c 2007
|
| 300 |
|
|
|a XI, 156 S.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a WHO technical report series
|v 943
|
| 500 |
|
|
|a Literaturangaben
|
| 655 |
|
7 |
|a Konferenzschrift
|0 (DE-588)1071861417
|0 (DE-627)826484824
|0 (DE-576)433375485
|2 gnd-content
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4045699-7
|0 (DE-627)104162406
|0 (DE-576)209066407
|a Pharmazeutische Technologie
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 711 |
2 |
9 |
|a Meeting. WHO Expert Committee on Specifications for Pharmaceutical Preparations
|n 41
|c Geneva
|d 2006.10.16-20
|
| 810 |
2 |
|
|a Weltgesundheitsorganisation
|t WHO technical report series
|v 943
|9 943
|w (DE-627)129111813
|w (DE-576)034177582
|w (DE-600)30965-5
|x 0512-3054
|7 ns
|
| 856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/532190548.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a ISIL_DE-1a
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a GBV_ILN_74
|
| 912 |
|
|
|a ISIL_DE-354
|
| 912 |
|
|
|a GBV_ILN_252
|
| 912 |
|
|
|a GBV_ILN_252_i110
|
| 936 |
b |
k |
|a 58.28
|j Pharmazeutische Technologie
|0 (DE-627)106417622
|
| 936 |
b |
k |
|a 44.40
|j Pharmazie
|j Pharmazeutika
|0 (DE-627)106423304
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 11
|1 01
|x 0001
|b 855307064
|c 00
|f 2
|d 1 A 667302
|e u
|j --%%--
|y k
|z 02-03-09
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 823551598
|c 00
|f --%%--
|d 2867-9646
|e --%%--
|j --%%--
|y k
|z 18-06-07
|
| 980 |
|
|
|2 74
|1 01
|x 0354
|b 823290743
|c 00
|f Magazin
|d MA 1509-943
|e u
|j --%%--
|y z
|z 15-06-07
|
| 980 |
|
|
|2 252
|1 01
|x 4252/110
|b 914897098
|c 00
|f B12-ls
|d III X a 5
|e u
|j --%%--
|y zi110
|z 15-12-08
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 00
|a Pharmaceutical Preparations-standards
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 01
|a Pharmacopoeias as Topic
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 02
|a Reference Standards
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 50
|a Congresses
|
| 984 |
|
|
|2 11
|1 01
|x 0001
|a 150542616010
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$028679646
|
| 984 |
|
|
|2 74
|1 01
|x 0354
|a 354$12418382
|
| 985 |
|
|
|2 74
|1 01
|x 0354
|a MA 1509-943
|
| 985 |
|
|
|2 252
|1 01
|x 4252/110
|a 08Abo/III X a 5
|
